Long-term Outcomes of Patients After Coronary Bifurcation Stenting
NCT ID: NCT00325884
Last Updated: 2024-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2001-08-31
2005-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Short Term Outcome of Different Bifurcation Stenting Techniques at Assuit University Cath. Lab
NCT03266289
Two-stent vs Provisional Stenting Techniques for Patients With Complex Coronary Bifurcation Lesions
NCT02284750
Treatment Of Coronary Bifurcation Lesions: Stentcovering Of The Side Branch With And Without PCI Of The Side Branch: A Retrospective Analysis Of All Consecutive Patients
NCT01538186
Bifurcation Coronary Lesion 0-0-1
NCT06446102
POLish Bifurcation Optimal Stenting Study
NCT02192840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Long-term clinical outcomes are important from the patients point of view and also determine the use of resources. Knowledge of the long-term outcomes from the various techniques used to treat bifurcation lesions would be important in determining guidelines for the treatment of bifurcation lesions. If simple techniques offer similar or better outcomes than more complex strategies, then this would justify simpler techniques such as main vessel stenting that would use less resources, expose the patient to less radiation, and contrast related to prolonged angioplasty procedures.
Comparisons: We will compare the long-term outcomes of simple versus complex stent techniques, and determine other risk factors for long-term outcome
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* lesions involve the ostium of a side branch artery
* main branch and side branch with reference diameters of at least 2mm
* at least one stent used to treat the lesion
Exclusion Criteria
* reference side branch artery less than 2mm diameter
* multiple bifurcation lesions
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Boston Healthcare System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Scott Kinlay
Director, Cardiac Catheterization Laboratory
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Kinlay, MBBS, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Boston Healthcare System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Boston Healthcare System
West Roxbury, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zamani P, Kinlay S. Relationship of side-branch intervention and drug-eluting stents to long-term outcomes after coronary bifurcation stenting. J Am Coll Cardiol 2008; 51(suppl B): B50-B51
Zamani P, Kinlay S. Long-term risk of clinical events from stenting side branches of coronary bifurcation lesions with drug-eluting and bare-metal stents: an observational meta-analysis. Catheter Cardiovasc Interv. 2011 Feb 1;77(2):202-12. doi: 10.1002/ccd.22750.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VABHS-IRB-1934
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.